Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Ethical problems with bioidentical hormone therapy

International Journal of Impotence Research volume 20, pages 45–52 (2008)Cite this article

Abstract

The term ‘bioidentical’ hormone replacement therapy (BHRT) is widely misunderstood by the patient population and misrepresented in patient literature. Within the clinical community, BHRT is currently being prescribed by some as an ‘innovative therapy’ with no published evidence in peer-reviewed journals that it is better than the current standard of care; in at least one case, BHRT is being used as a study agent in unregulated and unethical research involving very high doses of estrogen and progesterone. Additionally, professional ethics problems abound within the prescribing population, since those claiming expertise and training in BHRT vary widely in competencies, may cross practice boundaries, and may have overt conflicts of interest if they are selling or promoting their own for-profit recipes of BHRT on commercial forums. Ultimately, BHRT presents clinical, research and professional ethics problems that are discussed in depth.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Boothby LA, Doering PL, Kipersztok S . Bioidentical hormone therapy: a review. Menopause 2004; 11: 356–367.

    Article  Google Scholar 

  2. Fugh-Berman A, Bythrow J . Bioidentical hormones for menopausal hormone therapy: variation on a theme. J Gen Intern Med 2007; 22: 1030–1034.

    Article  Google Scholar 

  3. Wright J, Morganthaler J . Natural Hormone Replacement For Women Over 45. Smart Publications: Petaluma, California, 1997.

    Google Scholar 

  4. Wright JV . Bio-identical steroid hormone replacement: selected observations from 23 years of clinical and laboratory practice. Ann NY Acad Sci 2005; 1057: 506–524.

    Article  CAS  Google Scholar 

  5. Wright JV . Disputes definition of ‘hormone replacement therapy’. Altern Ther Health Med 1996; 2: 20.

    CAS  PubMed  Google Scholar 

  6. Greene R, Dalton K . The premenstrual syndrome. BMJ 1953; 1: 1007–1014.

    Article  CAS  Google Scholar 

  7. Dalton K . Comparative trials of new oral progestogenic compounds in treatment of premenstrual syndrome. BMJ 1959; 2: 1307–1309.

    Article  CAS  Google Scholar 

  8. Dalton K . Progesterone or progestogens? BMJ 1976; 2: 1257.

    Article  CAS  Google Scholar 

  9. Dalton K . The aetiology of premenstrual syndrome is with the progesterone receptors. Med Hypotheses 1990; 31: 323–327.

    Article  CAS  Google Scholar 

  10. Oransky I . Katharina Dorothea Dalton. Lancet 2004; 364: 1576.

    Article  Google Scholar 

  11. Lee JR . Natural Progesterone: The Multiple Roles of a Remarkable Hormone.2nd edn. Jon Carpenter: Chipping Norton, 1999.

  12. Lee JR . Topical progesterone. Menopause 2003; 10: 374–377; author reply 7–9.

    Article  Google Scholar 

  13. Cirigliano M . Bioidentical hormone therapy: a review of the evidence. J Women's Health 2007; 16: 600–631.

    Article  Google Scholar 

  14. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–333.

    Article  CAS  Google Scholar 

  15. Food and Drug Administration. Food and drug administration labeling guidance for noncontraceptive estrogen drug products for the treatment of vasomotor symptoms and vulvar and vaginal atrophy symptoms—prescribing information for health care providers and patient labeling, revision 1. Center for Drug Evaluation and Research (CDER), revision 1. Available at http://www.fda.gov/cder/guidance/index.htm; 2004.

  16. Naughton MJ, Jones AS, Shumaker SA . When practices, promises, profits, and policies outpace hard evidence: the post-menopausal hormone debate. J Soc Issues 2005; 61: 159–179.

    Article  Google Scholar 

  17. Somers S . Ageless: The Naked Truth About Bioidentical Hormones. Crown Publishers: New York, 2006; pp xxiii, 8,47,93.

    Google Scholar 

  18. The Endocrine Society. Position Statement: Bioidentical Hormones 2006.

  19. Dr Randolph's Hormone Well online resource. http://www.hormonewell.com. Accessed July 20, 2007.

  20. Rosensweet D . http://www.rosensweetmd.com. Accessed July 20, 2007.

  21. Schwartz E . http://www.drerika.com. Accessed July 20, 2007.

  22. Join the Revolution. The Wiley protocol, 2007. Accessed March 17, 2007, at: http://www.thewileyprotocol.com.

  23. Ahmad F, Hudak PL, Bercovitz K, Hollenberg E, Levinson W . Are physicians ready for patients with Internet-based health information? J Med Internet Res 2006; 8: e22.

    Article  Google Scholar 

  24. Alpert JS . Online buyers beware: a warning for physicians and patients. Am J Med 2006; 119: 623.

    Article  Google Scholar 

  25. Anton B, Nelson R . Literacy, consumer informatics, and health care outcomes: interrelations and implications. Stud Health Technol Inform 2006; 122: 49–53.

    PubMed  Google Scholar 

  26. Ayantunde AA, Welch NT, Parsons SL . A survey of patient satisfaction and use of the Internet for health information. Int J Clin Pract 2007; 61: 458–462.

    Article  CAS  Google Scholar 

  27. Oermann MH, DiBartolomeo RA, Mahfet SA . HRT & the world wide web. Helping patients find good information on the web. AWHONN Lifelines 2002; 6: 526–532.

    Article  Google Scholar 

  28. Ravitch S, Fleisher L, Torres S . What websites are patients using: results of a tracking study exploring patients use of websites at a multi-media patient education center. AMIA Annu Symp Proc 2005; 1092.

  29. Wiley TS, Taguchi J, Formby B . Sex, Lies and Menopause: The Shocking Truth About Hormone Replacement Therapy. HarperCollins: New York, 2003.

    Google Scholar 

  30. National Institutes of Health. National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms. Ann Intern Med 2005; 142: 1003–1013.

    Article  Google Scholar 

  31. Reed M, Anderson C . Evaluation of patient information Internet web sites about menopause and hormone replacement therapy. Maturitas 2002; 43: 135–154.

    Article  Google Scholar 

  32. Sillence E, Briggs P, Harris PR, Fishwick L . How do patients evaluate and make use of online health information? Soc Sci Med 2007; 64: 1853–1862.

    Article  Google Scholar 

  33. Flynn KE, Smith MA, Freese J . When do older adults turn to the Internet for health information? Findings from the Wisconsin Longitudinal Study. J Gen Intern Med 2006; 21: 1295–1301.

    Article  Google Scholar 

  34. James N, Daniels H, Rahman R, McConkey C, Derry J, Young A . A study of information seeking by cancer patients and their carers. Clin Oncol (R Coll Radiol) 2007; 19: 356–362.

    Article  CAS  Google Scholar 

  35. Kivits J . Informed patients and the Internet: a mediated context for consultations with health professionals. J Health Psychol 2006; 11: 269–282.

    Article  Google Scholar 

  36. Sajid MS, Iftikhar M, Monteiro RS, Miles AF, Woods WG, Baig MK . Internet information on colorectal cancer: commercialization and lack of quality control. Colorectal Dis 2007.

  37. Levine RJ . Ethics and Regulation of Clinical Research 2nd edn. Yale University Press: New Haven, 1988.

    Google Scholar 

  38. Ernst E, Cohen MH, Stone J . Ethical problems arising in evidence based complementary and alternative medicine. J Med Ethics 2004; 30: 156–159.

    Article  CAS  Google Scholar 

  39. Suzanne Somers debates doctor. Transcripts.Larry King Live: CNN, A Time Warner Company; November 16, 2006.

  40. Curcio JJ, Wollner DA, Schmidt JW, Kim LS . Is bio-identical hormone replacement therapy safer than traditional hormone replacement therapy? A critical appraisal of cardiovascular risks in menopausal women. Treat Endocrinol 2006; 5: 367–374.

    Article  CAS  Google Scholar 

  41. What is the Wiley protocol? The Wiley Protocol. Accessed March 16, 2007, at http://www.thewileyprotocol.com.

  42. Stefanick ML . Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration. The American J Med 2005; 118 (Suppl 12B): 64–73.

    Article  Google Scholar 

  43. Couzin J, Miller G . NIH budget: boom and bust. Science 2007; 316: 356–361.

    Article  CAS  Google Scholar 

  44. Leonetti HB, Longo S, Anasti JN . Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss. Obstet Gynecol 1999; 94: 225–228.

    CAS  PubMed  Google Scholar 

  45. Leonetti HB, Landes J, Steinberg D, Anasti JN . Transdermal progesterone cream as an alternative progestin in hormone therapy. Altern Ther Health Med 2005; 11: 36–38.

    PubMed  Google Scholar 

  46. Leonetti HB, Wilson KJ, Anasti JN . Topical progesterone cream has an antiproliferative effect on estrogen-stimulated endometrium. Fertil Steril 2003; 79: 221–222.

    Article  Google Scholar 

  47. Moskowitz D . A comprehensive review of the safety and efficacy of bioidentical hormones for the management of menopause and related health risks. Altern Med Rev 2006; 11: 208–223.

    PubMed  Google Scholar 

  48. Hotze S . Hormones, Health and Happiness: A Natural Medical Formula for Rediscovering Youth. Forrest Publishing: Houston, 2005.

    Google Scholar 

  49. Shomon M . Living Well with Hypothyroidism: What Your Doctor Doesn’t Tell You that You Need to Know. Avon: New York, 2000.

    Google Scholar 

  50. About.com: Thyroid. Protect Your Right to Bio-identical Hormones. Posted to:: http://thyroid.about.com/od/publicawarenessoutreach/a/bioidentical.htm. Accessed July 20, 2007.

  51. Project aware. Association of Women for the Advancement of Research and Education at http://www.project-aware.org. Accessed July 20, 2007.

  52. Alsawaf MA, Jatoi A . Shopping for nutrition-based complementary and alternative medicine on the Internet: how much money might cancer patients be spending online? J Cancer Educ 2007; 22: 174–176.

    Article  Google Scholar 

  53. Humpel N, Jones SC . Gaining insight into the what, why and where of complementary and alternative medicine use by cancer patients and survivors. Eur J Cancer Care (Engl) 2006; 15: 362–368.

    Article  CAS  Google Scholar 

  54. Sherwin S . Belmont revisited through a feminist lens.In: Childress JF, Meslin EM, Shapiro HT (eds). Belmont Revisited: Ethical Principles for Research with Human Subjects. Georgetown University Press: Washington, DC, 2005, pp 148–164.

    Google Scholar 

  55. Childress JF, Meslin EM, Shapiro HT . Belmont Revisited: Ethical Principles for Research with Human Subjects. Georgetown University Press: Washington, DC, 2005; 256, pp.

    Google Scholar 

  56. Somers S . TS Wiley: rhythmic cycling. In: Ageless: The Naked Truth About Bioidentical Hormones. Crown Publishers: New York, 2006, pp 154–165.

    Google Scholar 

  57. How hard is it to get the Wiley protocol? The Wiley Protocol. Accessed March 17, 2007 at http://www.thewileyprotocol.com.

  58. Schwartz E, Schwarzbein D, Rosensweet D, Randolph Jr CWR, Northrup C, Murray J et al. Letter to Managing Editor, Crown Publishers,October 11, 2006. Posted at: http://drerika.typepad.com/notepad/2006/10/letter_to_suzan.html.

  59. Finding a Wiley protocol doctor or prescriber. The Wiley Protocol. Accessed March 17, 2007 at: http://www.thewileyprotocol.com.

  60. Participate in data gathering. The Wiley Protocol, Accessed March 17, 2007 at: http://www.thewileyprotocol.com.

  61. Feig S, Hynote E, Speight N, Magaziner A, Miranda RA, Schachter MB . Summary of the American College for Advancement in Medicine May 2005 Conference. Evid Based Complement Altern Med 2005; 2: 413–419.

    Article  Google Scholar 

  62. Somers S . Effects of aging; bioidentical hormones and aging; sex, sleep and stress; Dr Julie Taguchi: breast cancer; TS Wiley: rhythmic cycling.In: Ageless: The Naked Truth About Bioidentical Hormones. Crown Publishers: New York, 2006,pp 86–87;105–9; 18–29; 54–65; 232.

    Google Scholar 

  63. Food and Drug Administration (FDA). Drugs for Human Use 21 C.F.R., Part 312.60.

  64. Why the Wiley protocol? The Wiley Protocol. Accessed March 17, 2007 at: http://www.thewileyprotocol.com.

  65. Our Wiley protocol history. RhythmicLiving.org. Accessed March 27, 2007 at: http://rhythmicliving.org.

  66. Wiley Systems. Wiley Protocol Registered Pharmacy Registration Agreement 2007.

  67. Food and Drug Administration (FDA). Drugs For Human Use 21 C.F.R., Part 312.7(d).

  68. Dickens BM . Health care practitioners and HIV: rights, duties and liabilities.In: Jaysuriya DC (ed). HIV Law, Ethics and Human Rights—Text and Materials. New United Nations Development Programme, Regional Project on HIV and Development: Delhi, 1995,pp 66–98.

    Google Scholar 

  69. Etchells E, Sharpe G, Elliott C, Singer PA . Bioethics for clinicians: 3. Capacity. CMAJ 1996; 155: 657–661.

    CAS  PubMed  PubMed Central  Google Scholar 

  70. Mastroianni AC, Faden RR, Federman DD, Institute of Medicine (US). Committee on the Ethical and Legal Issues Relating to the Inclusion of Women in Clinical Studies. Women and Health Research: Ethical and Legal Issues of Including Women in Clinical Studies. National Academy Press: Washington, DC, 1994.

    Google Scholar 

  71. Etchells E, Sharpe G, Burgess MM, Singer PA . Bioethics for clinicians: 2. Disclosure. CMAJ 1996; 155: 387–391.

    CAS  PubMed  PubMed Central  Google Scholar 

  72. Etchells E, Sharpe G, Dykeman MJ, Meslin EM, Singer PA . Bioethics for clinicians: 4. Voluntariness. CMAJ 1996; 155: 1083–1086.

    CAS  PubMed  PubMed Central  Google Scholar 

  73. Etchells E, Sharpe G, Walsh P, Williams JR, Singer PA . Bioethics for clinicians: 1. Consent. CMAJ 1996; 155: 177–180.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Behavioral Science, Program for Bioethics and Patients’ Rights, University of Kentucky, College of Medicine, Lexington, KY, USA

    M S Rosenthal

Authors
  1. M S Rosenthal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M S Rosenthal.

Additional information

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosenthal, M. Ethical problems with bioidentical hormone therapy. Int J Impot Res 20, 45–52 (2008). https://doi.org/10.1038/sj.ijir.3901622

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3901622

Keywords

Search

Advanced search

Quick links